N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide

C20H22BrF3N4O2 — CID 137377216

IUPACN-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide
SMILESC[C@H]1CN(c2cc(F)c(Br)cc2NC(=O)c2cn(C)c(=O)cc2C(F)F)CCN1C
InChIInChI=1S/C20H22BrF3N4O2/c1-11-9-28(5-4-26(11)2)17-8-15(22)14(21)7-16(17)25-20(30)13-10-27(3)18(29)6-12(13)19(23)24/h6-8,10-11,19H,4-5,9H2,1-3H3,(H,25,30)/t11-/m0/s1
InChIKeyCCQJFPDNUYKIJW-NSHDSACASA-N
MW487.32 g/mol
LogP3.62
Rot. Bonds4

About N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide

N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide (PubChem CID 137377216) has the molecular formula C20H22BrF3N4O2 and a molecular weight of 487.32 g/mol. Its IUPAC name is N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide.

Molecular Properties

Compound NameN-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide
PubChem CID137377216
Molecular FormulaC20H22BrF3N4O2
Molecular Weight487.32 g/mol
Exact Mass486.09
IUPAC NameN-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide
SMILESC[C@H]1CN(c2cc(F)c(Br)cc2NC(=O)c2cn(C)c(=O)cc2C(F)F)CCN1C
InChIInChI=1S/C20H22BrF3N4O2/c1-11-9-28(5-4-26(11)2)17-8-15(22)14(21)7-16(17)25-20(30)13-10-27(3)18(29)6-12(13)19(23)24/h6-8,10-11,19H,4-5,9H2,1-3H3,(H,25,30)/t11-/m0/s1
InChIKeyCCQJFPDNUYKIJW-NSHDSACASA-N
XLogP3.62
TPSA57.58 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500487.32
LogP ≤ 53.62
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide?
The IUPAC name of N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide (CID 137377216) is N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide.
What is the SMILES notation for N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide?
The canonical SMILES for N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide is C[C@H]1CN(c2cc(F)c(Br)cc2NC(=O)c2cn(C)c(=O)cc2C(F)F)CCN1C.
What is the InChIKey of N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide?
The InChIKey is CCQJFPDNUYKIJW-NSHDSACASA-N. The full InChI is InChI=1S/C20H22BrF3N4O2/c1-11-9-28(5-4-26(11)2)17-8-15(22)14(21)7-16(17)25-20(30)13-10-27(3)18(29)6-12(13)19(23)24/h6-8,10-11,19H,4-5,9H2,1-3H3,(H,25,30)/t11-/m0/s1.
What are the key properties of N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide?
N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide has a molecular weight of 487.32 g/mol, XLogP of 3.62, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-bromo-2-[(3S)-3,4-dimethylpiperazin-1-yl]-4-fluorophenyl]-4-(difluoromethyl)-1-methyl-6-oxopyridine-3-carboxamide is sourced from PubChem (CID 137377216), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).